Insider Cluster (2 insiders) ·Filed Jul 8, 2026

PTCT

PTC THERAPEUTICS, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $776K total
Actionable Insight • Neutral

Monitor for any upcoming corporate events (earnings, pipeline updates) that could explain the timing, but this cluster alone does not signal insider concern. No trade action warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
PTCT ▼ -26.86% at T+60d
NEUTRAL call ✗ call lost -26.86% · α vs SPY -29.17% · entry $88.57 → $64.78
Entry anchored
Jul 7, 03:59 PM ET
via exchange tick
T+1d
+1.11%
call +1.11% · α +0.26%
$89.55
settled 3mo ago
T+5d
-11.87%
call -11.87% · α -12.73%
$78.06
settled 3mo ago
T+20d
-21.86%
call -21.86% · α -25.13%
$69.21
settled 8w ago
T+60d
-26.86%
call -26.86% · α -29.17%
$64.78
settled 2d ago

Price Chart

Loading chart...

Executive Summary

Two C-suite insiders (CTOO and EVP/CLO) sold a total of ~$2.6M in shares on July 6-7, 2026, predominantly tied to option exercises. The total value represents only ~0.036% of PTCT's $7.3B market cap, making this a routine liquidity-driven cluster. No bearish signal is warranted.

Key Financial Metrics

Direction
selling
Total Value
$2.6M
Insiders
2

Key Facts

  • Chief Technical Operations Officer Neil Gregory Almstead sold ~$2.19M in open-market shares (net of option exercises).
  • EVP and CLO Mark Elliott Boulding sold ~$406K in open-market shares (net of option exercises).
  • Total open-market sale value of ~$2.59M is only 0.036% of PTCT's market cap.
  • All sales coincide with option exercises, consistent with typical tax/vesting-related liquidity planning.

Financial Impact

~$2.59M in insider sales, immaterial relative to $7.3B market cap

dilution

Risk Factors

  • No material insider selling risk identified
  • Routine option-exercise-related sales do not imply negative outlook

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
81% bullish (21 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PTCT-1783576913200
15 reports for PTCT
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+60▲ +19.01%Apr 28, 2026
Filters
Rows
Reports for PTCT — sortable, filterable
TypeNow
Aug 21, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$69.82 $65.26▼ −6.53%▼ −6.00%$63.46 (−9.11%)
Jul 16, 2026
11w ago
Press Release
BEARISH ★ 7/10
$78.52 $71.97▲ +8.34%▲ +11.96%$63.46 (+19.18%)
Jul 16, 2026
11w ago
Insider Cluster
NEUTRAL ★ 3/10
$78.52 $71.97▼ −8.34%▼ −11.96%$63.46 (−19.18%)
Jul 13, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$81.33 $74.63▼ −8.24%▼ −11.42%$63.46 (−21.97%)
Jul 8, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$88.57 $69.21▼ −21.86%▼ −25.13%$63.46 (−28.35%)
Jun 26, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$81.57 $76.82▼ −5.82%▼ −5.54%$63.46 (−22.20%)
Jun 16, 2026
15w ago
8-K
NEUTRAL ★ 5/10
$73.27 $78.06▲ +6.54%▲ +6.34%$63.46 (−13.39%)
Jun 9, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$73.35 $89.55▲ +22.09%▲ +18.46%$63.46 (−13.48%)
May 19, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$71.02 $78.98▲ +11.21%▲ +10.47%$63.46 (−10.64%)
May 15, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$70.15 $73.27▲ +4.45%▲ +2.87%$63.46 (−9.54%)
Showing 10 of 15

US Market Status

Market Closed — Opens Mon (65h)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 9, 2026